Consolidated Statement Of Profit Or Loss

Astellas Pharma Inc. - Filing #7565071

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
1,518,619,000,000 JPY
1,296,163,000,000 JPY
Cost of sales
288,353,000,000 JPY
253,009,000,000 JPY
Gross profit
1,230,266,000,000 JPY
1,043,154,000,000 JPY
Selling, general and administrative expenses
630,272,000,000 JPY
548,840,000,000 JPY
Other income
3,642,000,000 JPY
15,256,000,000 JPY
Other expenses
157,515,000,000 JPY
104,314,000,000 JPY
Operating profit (loss)
133,029,000,000 JPY
155,686,000,000 JPY
Finance income
8,110,000,000 JPY
6,149,000,000 JPY
Finance costs
8,779,000,000 JPY
4,949,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,260,000,000 JPY
489,000,000 JPY
Profit (loss) before tax
132,361,000,000 JPY
156,886,000,000 JPY
Income tax expense
33,647,000,000 JPY
32,800,000,000 JPY
Profit (loss)
JPY
98,714,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
98,714,000,000 JPY
98,714,000,000 JPY
JPY
JPY
JPY
JPY
JPY
124,086,000,000 JPY
JPY
124,086,000,000 JPY
JPY
124,086,000,000 JPY
JPY
JPY
Profit (loss) attributable to
Owners of parent
98,714,000,000 JPY
124,086,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
54.24
67.08
Diluted earnings (loss) per share
54.09
67.05

Talk to a Data Expert

Have a question? We'll get back to you promptly.